Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-021383
Filing Date
2024-02-13
Accepted
2024-02-13 17:08:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv01376-lyellimmunopharmainc.htm SC 13G/A 11474
  Complete submission text file 0001104659-24-021383.txt   13026
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Subject) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93402 | Film No.: 24628870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)